Metlife Inc (NYSE:MET) shares traded 0.29% up during most recent session to reach at the closing price of $44.7. The stock exchanged hands 3.45 Million shares versus average trading capacity of 6.38 Million shares, yielding a market cap of $42.95 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $50.5 within the next 52-weeks. The mean target projections are based on 16 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Metlife Inc (NYSE:MET) high price target of $63 and with a conservative view have low price target of $37.

Bank of America “Upgrades” Metlife Inc (NYSE:MET) in a research note issued to investors on 1/16/19 to Buy with price target of $0.

Additionally on 12/17/18 RBC Capital “Maintained” Metlife Inc (NYSE:MET) to Outperform setting price target at $50 and on 11/13/18 Morgan Stanley “Maintained” the stock to Equal-Weight at $54. Furthermore on 10/08/18 UBS “Maintained” the stock to Neutral at $49.

On the other hand the company has Relative Strength Index (RSI 14) of 50.89 along with Average True Range (ATR 14) of 0.82, Consequently Metlife Inc (NYSE:MET)’s weekly and monthly volatility is 1.47%, 1.61% respectively. The company’s beta value is at 1.18.

In terms of Buy, Sell or Hold recommendations, Metlife Inc (NYSE:MET) has analysts’ mean recommendation of 2.3. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Metlife Inc (NYSE:MET)’s minimum EPS for the current quarter is at $1.06 and can go high up to $1.35. The consensus mean EPS for the current quarter is at $1.28 derived from a total of 17 estimates from the analysts who have weighed in on projected earnings. However the company reported $1.36 earnings per share for the same quarter during last year.

Previously Metlife Inc (NYSE:MET) reported $1.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.07. The company posted an earnings surprise of 5.5%.

Metlife Inc (NYSE:MET)’s revenue estimates for the current quarter are $15.97 Billion according to 6 number of analysts, for the current quarter the company has high revenue estimates of $16.49 Billion in contradiction of low revenue estimates of $15.43 Billion. For the current year the company’s revenue estimates are $64.86 Billion compared to low analyst estimates of $62.27 Billion and high estimates of $67.27 Billion according to 9 number of analysts.

Currently Metlife Inc (NYSE:MET)’s shares owned by insiders are 0.1%, whereas shares owned by institutional owners are 78.5%. However the six-month change in the insider ownership was recorded -0.68%, as well as three-month change in the institutional ownership was recorded -3.59%.

Metlife Inc (NYSE:MET)’s trailing twelve month revenues are $67.98 Billion, whereas its price to sales ratio for the same period is 0.63. Its book value per share for the most recent quarter is $53.83 while its price to book ratio for the same period is 0.83, as for as the company’s cash per share for the most recent quarter is $16.47, however its price to cash per share ratio for the same period is 2.71. The stock has 5 year expected PEG ratio of 0.91 whereas its trailing twelve month P/E ratio is 9.06.